Maasstad Ziekenhuis Stichting — Clinical Trial Site

83 Registered trials

38 Currently recruiting

Organisation

Maasstad Ziekenhuis Stichting

Location

Rotterdam, Netherlands

Identifier

ORG-100021669

Address

Maasstadweg 21, 3079 DZ, Netherlands

Departments

#1702: Interventional Cardiology
#2201; oncology
1801: Neurology
2204: Rheumatology
2301:Rheumatology
Brandwondencentrum
Burn Centre and Department of Surgery
Burn department
Cardiology
Department of Internal Medicine
Department of Medical Oncology
Dept. of Internal Medicine
Endocrinologie
Gastroenterology and Hepatology
Hematology
ICU
Intensive care
Internal Medicine
Internal Medicine / Dialysis
Internal medicine / Oncology
Internal Medicine and Hematology
Internal medicine/Oncology
Interne Geneeskunde
Longgeneeskunde
Maasstad
Maasstad Ziekenhuis
Medische Oncologie
N/A
Nephrology
Neurologie
Neurology
Obstetrics & Gynaeccology
Obstetrics & Gynecology
Oncologie
Oncology
Paediatric Gastroenterology
Pulmonology
Reproductive medicine and gynecology
Reumatologie
Reumatologie en Klinische Immunologie
Rheumatology
Rheumatology and Clinical Immunology
Surgery
Urology

Clinical trials at this site (83)

Search interface

SAFEST Not authorised

2022-502059-79-00 Ischemic stroke or transient ischemic attack 6
Sarilumab efficacy and safety in adults with early polymyalgia rheumatica Pending

2024-511296-15-00 Musculoskeletal diseases 5
COATS (genetic Clopidogrel response testing to finetune the antithrombotic regimen in (D)OAC Treated patients undergoing PCI) Study Pending

2024-512350-17-01 Patients with coronary artery disease and an indication 6
Tocilizumab Dose Optimization in Rheumatoid Arthritis Pending

2025-520513-30-00 Rheumatoid arthritis 6
A study to assess the safety and efficacy of different doses of ELV001 to treat active rheumatoid arthritis in patients with an inadequate r… Pending

2025-524005-32-00 Rheumatoid arthritis 4
Adjuvant Pembrolizumab in patients with early-stage triple negative breast cancer with residual disease after treatment with chemotherapy an… Pending

2025-524229-41-00 Triple negative breast cancer 5
HO182 CLL: Treatment of patients with chronic lymphocytic leukemia (CLL) with 6 cycles of rituximab in combination with 6 or 26 cycles of ve… Pending

2025-524283-38-00 Relapsed or refractory chronic lymphocytic leukemia 5
A Long-Term Extension Study of IMVT-1402 in Adult Patients With Graves' Disease Recruiting

2025-524001-33-00 Graves’ Disease 4 2026-05-22
Adjuvant chemotherapy for prevention of recurrence in patients with detectable ctDNA after surgery in high-riskrectal cancer. Recruiting

2024-517700-12-00 Rectal cancer 5 2025-12-10
T3-4-Hypo trial Recruiting

2024-513883-24-00 Hypothyroidism Triiodothyronine Quality of Life Persist 5 2025-11-02
A multicentre, intra-patient randomised controlled Phase III study to confirm the efficacy and safety of denovoSkin™, a bilayer engineered c… Recruiting

2023-507717-94-00 Deep partial and full-thickness burns 5 2024-12-06
A randomized, two-period crossover study to demonstrate the comparability of pharmacokinetics of subcutaneous ianalumab between 2mL auto-inj… Recruiting

2023-508996-35-00 Rheumatoid Arthritis 4 2024-11-18
Perioperative versus adjuvant FOLFIRINOX for resectable pancreatic cancer: the PREOPANC-3 study Recruiting

2024-510617-15-00 Non-metastatic resectable pancreatic cancer 5 2024-09-06
Combined Dose-Finding and CV Outcomes Study with CSL300 (Clazakizumab) in Adult Subjects with ESKD Undergoing Dialysis (POSIBIL6ESKD). Recruiting

2022-500273-14-00 Atherosclerotic cardiovascular disease in patients with 10 2023-07-17
HF-POLARIS: A research study to look at how well NNC0487-0111 works compared to placebo in people with heart failure and obesity Recruiting

2025-523717-29-00 HFpEF or HFmrEF and obesity 5 2026-04-28
A clinical study of tulisokibart to treat radiographic axial spondyloarthritis (MK-7240-013) Recruiting

2025-521059-21-00 Radiographic axial spondyloarthritis (as known as ankyl 4 2025-11-25
A Phase 2b Study to Assess the Efficacy and Safety of IMVT-1402 in Patients With Graves' Disease Recruiting

2025-521920-31-00 Graves’ Disease 4 2025-11-21
Shorter weaning from invasive ventilation with levosimendan: a randomized, double-blind, multicenter study in critically ill patients. Recruiting

2024-518810-23-00 Failure to wean from invasive ventilation. 6 2025-09-17
REDO-JAK: Dose REDuction Of JAnus Kinase inhibitors in patients with inflammatory rheumatic diseases Recruiting

2025-520757-36-00 Rheumatoid arthritis, psoriatic arthritis and axial spo 6 2025-09-15
Continuing ovulation induction with letrozole versus switching to gonadotropins in women with polycystic ovary syndrome (MOVIN-II study) Recruiting

2024-519354-36-00 Polycystic ovary syndrome (PCOS) 6 2025-08-01
StAtins in Frail oldEr patients with ischemic Stroke or Transient ischemic attack – The Randomized Controlled Trial Recruiting

2024-517343-31-00 Ischemic stroke and transient ischemic attack 6 2025-04-11
Treatment of ELectroencephalographic STatus epilepticus After cardiopulmonary Resuscitation-2 (TELSTAR-2): a multicenter randomised clinical… Recruiting

2024-516068-27-01 status epilepticus 5 2025-04-10
BuLLSEYE Recruiting

2024-512950-13-00 Sepsis 11 2025-01-03
Optimizing therapy with n=1-studies: negating the 'nocebo' effect in statin-intolerance Recruiting

2023-507489-20-00 Statin-intolerance 6 2024-12-10